Defining more than just a number

Helping our clients navigate complexity with confidence to craft a robust and communicable price strategy – credible from the boardroom to the negotiating table.

Connect with our Experts

How we can support

In rare diseases and oncology, pricing must strike a delicate balance of rewarding value, enabling access, and supporting innovation, all under intense scrutiny.

Pricing requires methodological rigour, creativity and strategic clarity. We recognise the need to go beyond research and consider different perspectives and analytical approaches.

At Prescient, we help our clients navigate complexity with confidence to craft a robust and communicable price strategy – credible from the boardroom to the negotiating table.


Our Pricing services

The numbers

Proven track record

0

+ Projects delivered

End-to-end experience

0

+ Negotiations supported

Deep research expertise

0

+ Pricing interviews conducted

News and Insights

Explore our latest insights, whitepapers, and event highlights to learn more about the latest developments and perspectives shaping the evolving healthcare landscape.

Discover all
Whitepaper

Innovative Contracting for ATMPs in Europe 

Find out more
Blog

What do the new Medicare negotiations mean for pipeline orphan therapies?

Find out more
Event

Exploring alternative pricing approaches for orphan medicines

Find out more
Blog

2025 themes for pricing and access success for rare disease and oncology medicines

Find out more
Event

Pricing and reimbursement of multiple indication medicines: Can a balance be found between different stakeholder perspectives to optimise value and access for patients, while ensuring sustainable and affordable innovation?

Find out more

Want to discuss your pricing needs with our experts?

If you’re interested in learning more about our services or would like to speak with the team, please get in touch.

Connect with our experts